Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine
- 1 January 1994
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 46 (4) , 345-349
Abstract
Dexmedetomidine is a novel α2-adrenoceptor agonist that may provide beneficial effects as premedication for anesthesia. The pharmacokinetics and pharmacodynamics of transdermal (TD) and intravenous (IV) dexmedetomidine were studied in nine healthy male subjects in a crossover trial. The TD preparation, containing 625 μg of dexmedetomidine base, was applied on the forehead and left in place for 12 h. The IV dose (2.0 μg·kg-1 as dexmedetomidine hydrochloride) was administered as an infusion over 5 min. Dose-normalized total AUC values were used to calculate dexmedetomidine bioavailability. The bioavailability of dexmedetomidine from the TD preparation was 51%. However, the bioavailability of dexmedetomidine released from the preparation was 88%. The mean terminal half-life was 3.1 h after IV and 5.6 h after TD administration. After TD administration, the mean maximal reductions in blood pressure (systolic/diastolic) and heart rate were 28/20 mmHg and 19 beats·min-1. A sedative effect was obvious within 5 min and 1–2 h after IV and TD administration, respectively.Keywords
This publication has 11 references indexed in Scilit:
- Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidineClinical Pharmacology & Therapeutics, 1992
- Percutaneous Absorption of DrugsClinical Pharmacokinetics, 1992
- Intravenous nicotine retards transdermal absorption of nicotine: Evidence of blood flow–limited percutaneous absorptionClinical Pharmacology & Therapeutics, 1992
- The Effect of Intravenously Administered Dexmedetomidine on Perioperative Hemodynamics and Isoflurane Requirements in Patients Undergoing Abdominal HysterectomyAnesthesiology, 1991
- Dexmedetomidine, an α2-Adrenoceptor Agonist, Reduces Anesthetic Requirements for Patients Undergoing Minor Gynecologic SurgeryAnesthesiology, 1990
- Effects of dexmedetomidine, a selective α2-adrenoceptor agonist, on hemodynamic control mechanismsClinical Pharmacology & Therapeutics, 1989
- Absorption Characteristics of Transdermally Administered FentanylAnesthesiology, 1989
- Picogram level determination of medetomidine in dog serum by capillary gas chromatography with negative ion chemical ionization mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Dexmedetomidine Diminishes Halothane Anesthetic Requirements in Rats Through a Postsynaptic Alpha2 Adrenergic ReceptorAnesthesiology, 1988
- Transdermal drug delivery and cutaneous metabolismXenobiotica, 1987